Generic placeholder image

Current Cancer Drug Targets


ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance

Author(s): Yulong Shang, Xiqiang Cai and Daiming Fan

Volume 13, Issue 9, 2013

Page: [915 - 929] Pages: 15

DOI: 10.2174/15680096113136660097

Price: $65


Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer. Poor responses to drug treatment can result in metastasis, cancer dissemination and death. Recently, the epithelial-mesenchymal transition (EMT) has been found to play a critical role in cancer drug resistance, but the nature of this intrinsic link remains unclear. This review summarizes recent advances in the understanding of drug resistance and focuses especially on the association between EMT and drug resistance. We discuss the roles of EMT in regulating drug resistance across different types of cancer, focusing simultaneously on the molecular mechanisms and potential pathways involved in the regulation of drug resistance by EMT. In addition, we discuss potential therapeutic strategies to target EMT to reverse drug resistance.

Keywords: BCL-2, Cancer stem cell, drug resistance, EMT, microRNA, NF-B, P-glycoprotein.

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy